Albemarle Corporation (ALB) Institutional Ownership & Insider Trading

939 institutions reported holding Albemarle Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 10 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ALBAlbemarle CorporationFollow ALB — free

Specialty Chemicals · Basic Materials

—

Price chart with a free account

Market cap: 11.1B
P/E TTM: —
Dividend yield: 1.7%
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

939 institutions held 98.2% of the shares. Across filers that reported both quarters, shares held changed +5.3%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	939	116	+5.3%	289	92	315	139
Mar 26	972	108	+3.6%	282	163	279	81
Dec 25	884	106	-3.2%	226	185	253	76
Sep 25	741	109	-3.7%	215	118	225	57
Jun 25	686	113	+0.2%	222	60	228	121
Mar 25	743	111	-1.5%	210	66	261	105
Dec 24	775	113	+8.0%	210	68	276	98
Sep 24	778	103	-5.7%	273	68	248	110

Albemarle Corporation — questions

Who owns Albemarle Corporation stock?: 939 institutions reported Albemarle Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: Capital World Investors (8.4%), BlackRock, Inc. (8.1%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%).
Are Albemarle Corporation insiders buying or selling?: 10 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Albemarle Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.